|
Volumn 29, Issue 8, 2002, Pages 1403-1409
|
A new regimen for TS-1 therapy designed to minimize adverse reactions by introducing a one-week interval after each two-week dosing session
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC ANTIMETABOLITE;
OXONIC ACID;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
ADULT;
AGED;
ARTICLE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
STOMACH TUMOR;
ADMINISTRATION, ORAL;
ADULT;
AGED;
ANTIMETABOLITES, ANTINEOPLASTIC;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
OXONIC ACID;
PYRIDINES;
STOMACH NEOPLASMS;
TEGAFUR;
|
EID: 2242445287
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|